Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Harm reduction
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Alcohol and drug treatment
Health consequences
Digital technology - benefits and risks
Alcohol — Harm reduction
Harm reduction — Prevention
Harm reduction — Public health
Infectious diseases — Harm reduction
Nicotine/tobacco — Harm reduction
14:00
Emerging findings from a longitudinal evaluation
Police training to reduce drug-related harm in Mexico
14:00
14:05
Harm reduction response to amphetamine users
14:05
14:25
Harm reduction: mobile unti service for PWID in Latvia (launched during HAREACT)
14:25
10:50
Understanding and improving health and social outcomes
10:50
to
12:20
Networking zone 3 (N3)
Sanna Rönkä
Alcohol: epidemiology and adolescence
10:50
to
12:20
Central square 2 (C2)
Jorgen G. Bramness
Challenges for harm reduction I
10:50
to
12:20
Insights zone 2 (I2)
Meni Malliori
Poster guided tour
Progress in alcohol research and responses - EUFAS poster session 1
10:50
to
12:20
Guided poster tours room
Colin Drummond
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
Provision, available evidence and gaps
Drug-related interventions in European prisons
10:50
to
12:20
Insights zone 3 (I3)
Linda Montanari
Carina Ferreira Borges
Individually-tailored support and education for safer injection
10:50
to
12:20
Networking zone 2 (N2)
Carine Magen
Gender perspectives
10:50
to
12:20
Central square 3 (C3)
Anne Line Bretteville-Jensen
Alcohol perspectives and prevention - EUFAS poster session 2
10:50
to
12:20
Guided poster tours room
Linn Gjersing
13:20
online registration required
Digital health multi-sector co-ideation game jam
13:20
to
14:50
Futures zone 2 (F2)
Alexandra Estruch
Anna Sort
Heleen Riper
Matthijs Blankers
Nicotine harm reduction
13:20
to
14:50
Networking zone 4 (N4)
Ann McNeill
Treatment — challenges, determinants and responses
13:20
to
14:50
Networking zone 3 (N3)
Dominique Lopez
Risk behaviours in context
13:20
to
14:50
Networking zone 2 (N2)
Anja Busse
Injecting, risk and reducing harm
13:20
to
14:50
Networking zone 3 (N3)
Thomas Néfau
Focus on prescription drugs I
13:20
to
14:50
Insights zone 3 (I3)
Volker Auwärter
Policy and treatment
13:20
to
14:50
Insights zone 2 (I2)
Matthew Young
Reducing drug-related deaths
13:20
to
14:50
Central square 2 (C2)
Catherine Comiskey
15:00
Cooperation between harm reduction and law enforcement
Implementation of supervised drug consumption facilities in Zurich: a success story
15:00
to
16:30
Networking zone 2 (N2)
Florian Meyer
Epidemiology of hepatitis C among people who use drugs — Data to inform future planning
15:00
to
16:30
Insights zone 3 (I3)
Vana Sypsa
Jack Stone
Treatment interventions
15:00
to
16:30
Networking zone 3 (N3)
Kari Grasaasen
Alcohol: comorbidity, risk and consequences
15:00
to
16:30
Central square 3 (C3)
Geert Dom
Opioid-related deaths and other harms: current and emerging lessons - SSA poster session
15:00
to
16:30
Guided poster tours room
Sarah Welch
16:50
Harm reduction across addictions: Recent results and future directions
16:50
to
18:20
Insights zone 3 (I3)
Karl Mann
online registration required
Digital health multi-sector co-ideation game jam
16:50
to
18:20
Futures zone 2 (F2)
Alexandra Estruch
Anna Sort
Paul Wallace
Factors influencing recovery
16:50
to
18:20
Insights zone 3 (I3)
Eilish Gilvarry
New methods
16:50
to
18:20
Central square 2 (C2)
André Noor
18:30
Workforce development and training
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Consumption rooms: overcoming implementation challenges
18:30
to
19:30
Insights zone 4 (I4)
Ricardo Fuertes
Opioids — current and emerging lessons
18:30
to
19:30
Networking zone 4 (N4)
Roumen Sedefov
Nightlife, festivals and other recreational settings
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Developing new prevention strategies to improve the situation of clients and employees of harm reduction services
18:30
to
19:30
Networking zone 2 (N2)
Gabi Becker
Challenges for harm reduction II
18:30
to
19:30
Insights zone 3 (I3)
Alessandro Pirona
10:45
Opioid-related deaths: learning from epidemiological studies
10:45
to
12:15
Insights zone 3 (I3)
Sarah Welch
Therapeutic horizons II
10:45
to
12:15
Central square 1 (C1)
Felix Carvalho
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:50
Poster
Exposure to alcohol and/or cadmium changes status of bioelements in rat tests
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
'Drink to forget' – a case report
10:50
to
12:20
Guided poster tours room
Mariana Lázaro
Poster
Screening for alcohol-related cognitive impairments – a case study
10:50
to
12:20
Guided poster tours room
Luisa Gil
Poster
Neuroprotective role of argan oil against alcohol use disorders in adolescent wistar rat
10:50
to
12:20
Guided poster tours room
Hicham El Mostafi
Poster
Cadmium and/or ethanol increase oxidative stress in liver of the exposed rats
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
Screening and brief interventions for reducing alcohol consumption in a department of firefighters in the central region of Portugal
10:50
to
12:20
Guided poster tours room
Teresa Barroso
Poster
Court proceedings and actions taken by a probation officer in work with people addicted to alcohol.
10:50
to
12:20
Guided poster tours room
Ewelina Silecka-Marek
Poster
Elderly wellbeing and alcohol - a tricky cocktail
10:50
to
12:20
Guided poster tours room
Jakob Emiliussen
11:00
Short communication
Portuguese gender-sensitive harm reduction services: bridging the gap
11:00
to
11:10
Networking zone 3 (N3)
Oral presentation
Vital signs: the future of the harm reduction model in the National Health Service
11:00
to
11:15
Insights zone 2 (I2)
Marta Borges
Oral presentation
Are we addressing alcohol-attributable deaths?
11:00
to
11:15
Central square 2 (C2)
Francisco Goiana-da-Silva
11:10
Short communication
A change in the prescribing practice of prebagalin that has had a direct negative effect on drug-induced deaths in Ireland
11:10
to
11:20
Networking zone 3 (N3)
Ena Lynn
11:15
Oral presentation
Harm reduction and public health: the case of Sweden
11:15
to
11:30
Insights zone 2 (I2)
Lena Eriksson
Oral presentation
The long-term impact of the Israeli national program to reduce alcohol problem drinking among children and youth: a nine-year follow-up 2010-2019
11:15
to
11:30
Central square 2 (C2)
Yossi Harel-Fisch
11:30
Short communication
Performance enhancing drugs. Results from a Belgian survey on PED use among workers
11:30
to
11:40
Networking zone 3 (N3)
Marie-Claire Lambrechts
Oral presentation
Harm reduction drug policy in Israel: what has and still needs to be accomplished?
11:30
to
11:45
Insights zone 2 (I2)
Hagit Bonny-Noach
Oral presentation
Frequency of drinking in Europe and interplay between cultural and individual values
11:30
to
11:45
Central square 2 (C2)
11:40
Short communication
Drug and alcohol treatment: how much does it cost in Europe?
11:40
to
11:50
Networking zone 3 (N3)
Claudia Costa Storti
11:45
Oral presentation
Street Support Project: a harm reduction approach to urban health and integration
11:45
to
12:00
Insights zone 2 (I2)
Roberto Pérez Gayo
Oral presentation
Associations between negative life events and adolescent alcohol/drug-related problems, and the potential moderating role of individual and social resilience factors. The youth@hordaland-survey
11:45
to
12:00
Central square 2 (C2)
Ove Heradstveit
11:50
Short communication
Young people's exposure to gambling advertisements: a mixed methods study in Australia.
11:50
to
12:00
Networking zone 3 (N3)
Hannah Pitt
12:00
Short communication
Street Work Nursing as an innovative strategy in the care for dually diagnosed individuals: reflections on a pilot study
12:00
to
12:10
Networking zone 3 (N3)
Ilse Goethals
12:10
Short communication
Dissuasion, the effectiveness of the intervention and good practices
12:10
to
12:20
Networking zone 3 (N3)
Américo Gegaloto
13:30
Short communication
Smokeless tobacco (snus) use and intergenerational social mobility among adolescents during 10 years
13:30
to
13:40
Networking zone 4 (N4)
Short communication
Treating drug abuse and health issues in the criminal justice system. An empirical research on the linkage of health and criminal justice interventions, France
13:30
to
13:40
Networking zone 3 (N3)
Ivana Obradovic
Short communication
Perceptions on social determinants of opioid dependence recovery
13:30
to
13:40
Networking zone 3 (N3)
Leonor Brito
Oral presentation
Substance Use Sex Index (SUSI): towards a new behaviour change assessment tool
13:30
to
13:45
Networking zone 2 (N2)
Nadine Ezard
13:40
Short communication
Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of past-year smokers
13:40
to
13:50
Networking zone 4 (N4)
Erikas Simonavicius
Short communication
Reverse transition from injecting to smoking heroin and/or crack cocaine on lower methadone dose: sub-therapeutic dosing or safer drug use?
13:40
to
13:50
Networking zone 3 (N3)
Felicia Heidebrecht
13:45
Oral presentation
Chemsex experiences: pleasures, harms and care
13:45
to
14:00
Networking zone 2 (N2)
Maitena Milhet
13:50
Short communication
Co-use and co-quitting: predicting motivation to quit tobacco and cannabis among further education college students in the UK
13:50
to
14:00
Networking zone 4 (N4)
Hannah Walsh
Short communication
Benzodiazepine management in primary care: barriers and facilitators
13:50
to
14:00
Networking zone 3 (N3)
Kristien Coteur
14:00
Short communication
Implementation of financial incentives for successful smoking cessation in real-life company settings
14:00
to
14:10
Networking zone 4 (N4)
Gera Nagelhout
Oral presentation
The counselors’ perspective on the use of methamphetamine in a sexual context among men who have sex with men
14:00
to
14:15
Networking zone 2 (N2)
Valérie Aubut
Short communication
Referral of European and third country non-national clients in Belgian drug treatment
14:00
to
14:15
Networking zone 3 (N3)
Eva Blomme
14:10
Short communication
Challenges in tobacco control in Serbia
14:10
to
14:20
Networking zone 4 (N4)
Biljana Kilibarda
Short communication
HIV and drug abuse: relationship and treatment challenges
14:10
to
14:20
Networking zone 3 (N3)
Sara Dehanov
14:15
Oral presentation
Faster, higher, stronger? Results from a Belgian survey on PED use among gym-goers
14:15
to
14:30
Networking zone 2 (N2)
Bertrand Fincoeur
14:20
Short communication
Motivation for treatment predict adherence to treatment in a randomised clinical trial
14:20
to
14:30
Networking zone 3 (N3)
Zhanna Gaulen
14:30
Short communication
Psychiatric assessment of prisoners in opioid-maintenance treatment: emphasis on ADHD
14:30
to
14:40
Networking zone 3 (N3)
Marisa Silbernagl
14:40
Short communication
Perceptions on social determinants of opioid dependence recovery
14:40
to
14:50
Networking zone 3 (N3)
15:00
Oral presentation
The contribution of injecting drug use as a risk factor for Hepatitis C virus transmission globally, regionally, and at country level: a modelling study
15:00
to
15:15
Insights zone 3 (I3)
Adam Trickey
Oral presentation
Safe Injection Facilities Zurich - 30 years of experience
15:00
to
16:30
Networking zone 2 (N2)
Janine Lanz
Oral presentation
Implementation of a drug consumption room: conflict management - case analysis and success factors
15:00
to
16:30
Networking zone 2 (N2)
Simon Weis
Florian Meyer
Oral presentation
Security, Intervention, Prevention (SIP Zurich): conflicts of use in public spaces:
15:00
to
16:30
Networking zone 2 (N2)
Mara Brügger
15:15
Oral presentation
Factors associated with HIV and hepatitis C in the context of routes of drug administration among problem drug users in Latvia, 2018
15:15
to
15:30
Insights zone 3 (I3)
Laura Isajeva
15:30
Oral presentation
Barriers in the treatment of HCV infection in drug users: inspiring solutions from SCUDO project
15:30
to
15:45
Insights zone 3 (I3)
Felice Alfonso Nava
15:45
Oral presentation
HCV care in an opiate substitution therapy program: assessment of infection, liver-related damage, and treatment rates.
15:45
to
16:00
Insights zone 3 (I3)
Roberto Muga
16:00
Oral presentation
Slamming, drug injection in sexual contexts: increased HIV and HCV exposure for MSM points to a need for intersectional approaches to harm reduction
16:00
to
16:15
Insights zone 3 (I3)
Marie Jauffret-Roustide
16:15
Oral presentation
Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: a systematic review and meta-analysis
16:15
to
16:30
Insights zone 3 (I3)
Jason Grebely
17:00
Oral presentation
Harm reduction in drug addiction with special emphasis on women
17:00
to
17:15
Insights zone 3 (I3)
Gabriele Fischer
17:15
Oral presentation
New data support reduced alcohol consumption as harm reduction strategy in individuals with alcohol dependence
17:15
to
17:30
Insights zone 3 (I3)
Katie Witkiewitz
17:30
Oral presentation
e-cigarettes as harm reduction in smokers, what is the evidence?
17:30
to
17:45
Insights zone 3 (I3)
Henri-Jean Aubin
17:45
Oral presentation
Discussant
17:45
to
18:00
Insights zone 3 (I3)
Sir John Strang
18:30
Short communication
The peer in outreach teams: a specialist among specialists?
18:30
to
18:40
Networking zone 3 (N3)
Maria João Oliveira
Oral presentation
Acceptability and willingness to use a mobile drug consumption room in Lisbon
18:30
to
18:45
Insights zone 4 (I4)
Adriana Curado
18:40
Short communication
The Akan-model: a Norwegian model for preventing and handling alcohol, drugs and gambling problems in the workplace
18:40
to
18:50
Networking zone 3 (N3)
Camilla Lynne Bakkeng
18:45
Oral presentation
Drug consumption rooms – from a conceptual framework to a basic institutionalised service. The experience of Germany
18:45
to
19:00
Insights zone 4 (I4)
Ingo Michels
18:50
Short communication
Experiences of marketised welfare organisations among addiction treatment staff in Sweden
18:50
to
19:00
Networking zone 3 (N3)
Jessica Storbjörk
19:00
Short communication
Preparing effective addiction workforce: a challenge from the Czech perspective
19:00
to
19:10
Networking zone 3 (N3)
Amalie Pavlovská
Oral presentation
How to develop a common adherence of all the stakeholders when implementing a drug consumption room?
19:00
to
19:15
Insights zone 4 (I4)
Sanda Samitca
19:10
Short communication
Workforce development: the great paradox for the addictions sector
19:10
to
19:20
Networking zone 3 (N3)
Ann Roche
19:15
Oral presentation
Against political odds: the establishment of a drug consumption room in Belgium.
19:15
to
19:30
Insights zone 4 (I4)
Freya Vander Laenen
19:20
Short communication
Evidence-based practice and its many competing priorities: a qualitative analysis of substance misuse workers in English third-sector addiction treatment services
19:20
to
19:30
Networking zone 3 (N3)
Robert Calder
Thursday, 24 October
10:50
Oral presentation
Drug related interventions in European prisons: provision, available evidence, gaps
10:50
to
12:20
Insights zone 3 (I3)
Anna Tarjan
Oral presentation
Evidence and evidence-based interventions for people with drug related problems in prison settings
10:50
to
12:20
Insights zone 3 (I3)
Lara Tavoschi
Oral presentation
Implementation of harm reduction interventions in prison: what are the challenges
10:50
to
12:20
Insights zone 3 (I3)
Heino Stöver
Oral presentation
The first therapeutic community in French prisons: review and prospects
10:50
to
12:20
Insights zone 3 (I3)
Caroline Protais
Oral presentation
Evidence and practice: what are the challenges that drug professionals working in prison have to face
10:50
to
12:20
Insights zone 3 (I3)
Fadi Meroueh
Poster
Alcohol addiction as a social problem in Ukraine: history of research
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
The alcohol consumption in the modern Ukraine: tendences and perspecties.
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
Alcohol and drugs in contemporary school pupils on the verge of adolescence: the Polish experience
10:50
to
12:20
Guided poster tours room
Katarzyna Pawelek
Poster
The role of alcohol in fatal fires in Ireland
10:50
to
12:20
Guided poster tours room
Anne Doyle
Poster
Do parents want to change alcohol legislations to protect their children?
10:50
to
12:20
Guided poster tours room
Marta Zin-Sedek
Poster
Social and context determinants of drinking during working time – Portuguese GPS findings 2017
10:50
to
12:20
Guided poster tours room
Cláudia Urbano
Poster
Sub-groups of tobacco and alcohol co-use trajectories from ages 21 to 32: the Amsterdam growth and health longitudinal study
10:50
to
12:20
Guided poster tours room
Sterling McPherson
Poster
Effects of an alcohol prevention program at sport stadiums: a 2-year follow-up study using pseudopatrons and breath alcohol concentration levels
10:50
to
12:20
Guided poster tours room
Tobias Elgan
Poster
Implementing and evaluating alcohol and drug prevention methods at youth health clinics
10:50
to
12:20
Guided poster tours room
Pia Kvillemo
Poster
Accessing alcohol drinking influence in workplace – What is the panorama and current innovations in Portugal?
10:50
to
12:20
Guided poster tours room
Duarte Vital Brito
11:00
Short communication
Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance
11:00
to
11:10
Networking zone 4 (N4)
Patricia Gómez
Oral presentation
Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study
11:00
to
11:15
Central square 3 (C3)
Judit Tirado-Muñoz
Oral presentation
An interactive training session
11:00
to
11:15
Networking zone 2 (N2)
Richard Stranz
11:10
Short communication
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
11:10
to
11:20
Networking zone 4 (N4)
Lies Gremeaux
11:15
Oral presentation
A gendered approach to women’s lived experiences of gambling harm: preliminary findings
11:15
to
11:30
Central square 3 (C3)
Simone McCarthy
Oral presentation
Experiences from the field
11:15
to
11:30
Networking zone 2 (N2)
Joana Pires
11:20
Short communication
From chronology to processes: combining biographical interview with episodic analysis in a life story
11:20
to
11:30
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
11:30
Short communication
Coding multiple drug use in ICD-10 and ICD-11
11:30
to
11:40
Networking zone 4 (N4)
Espen Walderhaug
Oral presentation
How can partners influence the gambling habits of their gambler spouse?
11:30
to
11:45
Central square 3 (C3)
Melissa Cote
Oral presentation
The researcher perspective
11:30
to
11:45
Networking zone 2 (N2)
Perrine Roux
11:40
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Daniela Filipa Ferreira
11:45
Oral presentation
Methamphetamine use during pregnancy and weak evidence of adverse neonatal outcomes
11:45
to
12:00
Central square 3 (C3)
Roman Gabrhelik
Oral presentation
The importance of advocacy
11:45
to
12:00
Networking zone 2 (N2)
Eberhard Schatz
11:50
Short communication
The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia
11:50
to
12:00
Networking zone 4 (N4)
12:00
Short communication
Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review
12:00
to
12:10
Networking zone 4 (N4)
12:10
Short communication
Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland
12:10
to
12:20
Networking zone 4 (N4)
Michelle Foley
13:30
Short communication
Nurse-delivered injection education and subsequent injection drug use practices among street-involved youth
13:30
to
13:40
Networking zone 3 (N3)
Andreas Pilarinos
Oral presentation
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
13:30
to
13:45
Central square 2 (C2)
John Marsden
Oral presentation
Development of lower-risk gambling guidelines
13:30
to
13:45
Insights zone 2 (I2)
Matthew Young
Oral presentation
The off-prescription use of modafinil: an online survey of perceived risks and benefits
13:30
to
13:45
Insights zone 3 (I3)
Rachel Teodorini
13:40
Short communication
The impact of abused drugs spectrum among romanina IDU's on STI's, TB and blood born diseases in the last 10 years
13:40
to
13:50
Networking zone 3 (N3)
Adrian Abagiu
13:45
Oral presentation
Results of mortality cohort study of problem drug users in Poland.
13:45
to
14:00
Central square 2 (C2)
Janusz Sieroslawski
Oral presentation
Couple treatment of pathological gambling: variables associated with better efficacy
13:45
to
14:00
Insights zone 2 (I2)
Joel Tremblay
Oral presentation
Prospective cohort to assess the impact of removing non-prescription codeine in Australia
13:45
to
14:00
Insights zone 3 (I3)
Jacqui McCoy
13:50
Short communication
Zero new infections of HIV among PWID, 4 consecutive years, a reality in Macau
13:50
to
14:00
Networking zone 3 (N3)
Augusto Nogueira
14:00
Short communication
Theory versus practice, bacteriological efficiency versus personal habits. A bacteriological and user acceptability evaluation of filtering tools for people who inject drugs.
14:00
to
14:10
Networking zone 3 (N3)
Marie Jauffret-Roustide
Oral presentation
Coping strategies and dysfunctional symptomatoly in pathological gamblers.
14:00
to
14:15
Insights zone 2 (I2)
Paula Jauregui
Oral presentation
Characteristics and problematic opioid use in people prescribed opioids for CNCP over four years: a prospective cohort study
14:00
to
14:15
Insights zone 3 (I3)
Gabrielle Campbell
Oral presentation
Nasal naloxone for overdose prevention in Norway: results from the first four years
14:00
to
14:15
Central square 2 (C2)
Oral presentation
Nasal naloxone for overdose prevention in Norway: results from the first four years
14:00
to
14:15
Central square 2 (C2)
Desiree Eide
14:10
Short communication
C+ |Be+| Be your rights... an example of community mobilisation in a neighborhood with an open scene of drug consumption in Porto.
14:10
to
14:20
Networking zone 3 (N3)
Rui Miguel Coimbra Morais
14:15
Oral presentation
Incidence and predictors of drug overdoses among a cohort of patients treated for substance use disorder
14:15
to
14:30
Central square 2 (C2)
Birgitte Thylstrup
Oral presentation
A qualitative study of gabapentin use and misuse: perspectives of substance abuse treatment professionals
14:15
to
14:30
Insights zone 3 (I3)
Mance Buttram
Oral presentation
Determinants for the effectiveness of an Online Ambulatory Service for Internet Addicts (OASIS)
14:15
to
14:30
Insights zone 2 (I2)
Laura Bottel
14:20
Short communication
Innovative practices in harm reduction outreach teams in the city of Lisbon
14:20
to
14:30
Networking zone 3 (N3)
Inês Costa
Cristiana Merendeiro
14:30
Oral presentation
MDMA-related deaths in Australia
14:30
to
14:45
Central square 2 (C2)
Amanda Roxburgh
15:00
Poster
Dosing of naloxone in opioid overdose outside of hospital. Observational data 2014 -18 in Oslo, Norway
15:00
to
16:30
Guided poster tours room
Ida Tylleskär
Poster
Increasing trend and differential patterns of opioids prescribing by patient characteristics in primary care in Belgium: a registry-based study
15:00
to
16:30
Guided poster tours room
Catharina Matheï
Poster
Patterns in analgesic opioids use in Germany and France: improved pain management and risks of misuse
15:00
to
16:30
Guided poster tours room
Jessica Neicun
Poster
Barriers to establishing take-home naloxone programmes
15:00
to
16:30
Guided poster tours room
Sibella Hare Breidahl
Poster
Patient characteristics and expected needs: an opioid substitution programme findings
15:00
to
16:30
Guided poster tours room
Catarina Oliveira
Poster
Benzodiazepine use among patients in opioid substituttion treatment: a cross sectional study
15:00
to
16:30
Guided poster tours room
Catarina Oliveira
Poster
Hospitalisation of children after prenatal exposure to Methadone and Buprenorphine: national registry study from Czechia
15:00
to
16:30
Guided poster tours room
Blanka Nechanská
Poster
Uncovering trajectories of satisfaction with injectable opioid agonist treatment for severe opioid use disorder
15:00
to
16:30
Guided poster tours room
Kirsten Marchand
Poster
Predicting pain intensity following discontinuation of long-term opioid therapy among patients with and without substance use disorders
15:00
to
16:30
Guided poster tours room
Crystal Smith
Poster
Addressing the opioid crisis: engagement in multidisciplinary care
15:00
to
16:30
Guided poster tours room
Tianna Magel
Poster
Comparing rates and characteristics of harms across different pharmaceutical opioids: an examination of Australian ambulance attendances 2013-2018
15:00
to
16:30
Guided poster tours room
Tina Lam
15:10
Short communication
Psychedelic-assisted psychotherapy for the treatment of addictions: The future of addiction treatment?
15:10
to
15:20
Networking zone 3 (N3)
Anton Gomez-Escolar
Oral presentation
Predictive analysis of alcohol consumption and stress through the psychosocial variables of emotional intelligence and resilience
15:10
to
15:25
Central square 3 (C3)
Filipa Coelhoso
15:20
Short communication
Drug addiction in the immigrant population of users undergoing the low-threshold methadone maintenance programme in Lisbon
15:20
to
15:30
Networking zone 3 (N3)
Hugo Faria
15:25
Oral presentation
Harmful alcohol use among acutely ill hospitalised medical patients
15:25
to
15:40
Central square 3 (C3)
Saranda Kabashi
15:30
Short communication
Employment influence in recovering people who use drugs during opiate substitution treatment
15:30
to
15:40
Networking zone 3 (N3)
Ângela Leite
15:40
Short communication
Working with complex families with parental substance abuse: an overview of the parents under pressure program
15:40
to
15:50
Networking zone 3 (N3)
Sharon Dawe
Oral presentation
Somewhere to be: the spatiality’s of alcohol abuse and recovery in a non-interventionist, peer led centre.
15:40
to
15:55
Central square 3 (C3)
Kirstie Soar
17:00
Oral presentation
Interpreting wastewater data alongside other population-level indicators of stimulant use
17:00
to
17:15
Central square 2 (C2)
Hayley Jones
Oral presentation
Informal social support as a crucial factor in recovery from drug misuse
17:00
to
17:15
Insights zone 3 (I3)
Filipa Gonçalves
17:15
Oral presentation
What are the indirect causes of death among people who use drugs in Ireland? Findings from a comprehensive special register on drug related deaths
17:15
to
17:30
Central square 2 (C2)
Suzi Lyons
Oral presentation
Social and professional integration, addictive behaviours and time perspectives: personal experiences of young adults involved in a low-threshold employment program in Montreal
17:15
to
17:30
Insights zone 3 (I3)
Vincent Wagner
17:30
Oral presentation
Temporary and constant remission: a record-linkage study of a national cohort of people with psychoactive drug use disorders
17:30
to
17:45
Central square 2 (C2)
Morten Hesse
Oral presentation
General practice patients in treatment for substance use problems at different levels of care: an observational study using two data sources
17:30
to
17:45
Insights zone 3 (I3)
Nicole Boffin
17:45
Oral presentation
Effective policies to support autonomous attempts to quit opioid use - a cross-sectional study across 14 countries
17:45
to
18:00
Central square 2 (C2)
Larissa Maier
Oral presentation
The Healthy Addiction Treatment (HAT) recovery model for addiction nursing services
17:45
to
18:00
Insights zone 3 (I3)
Catherine Comiskey
18:00
Oral presentation
'Once a drug addict, always a drug addict': the role of stigma in recovery
18:00
to
18:15
Insights zone 3 (I3)
Joana Fonseca
18:30
Oral presentation
Re-emergence of injecting drug use-related HIV despite a comprehensive harm reduction environment
18:30
to
18:45
Insights zone 3 (I3)
Andrew McAuley
Oral presentation
New HCV prevention strategies and tools: lessons learnt
18:30
to
19:50
Networking zone 2 (N2)
Eberhard Schatz
Gabi Becker
18:40
Short communication
Opioid-related problems in Baltic States and Poland: has the turning point come?
18:40
to
18:50
Networking zone 4 (N4)
Katri Abel-Ollo
Short communication
Recommendations for NPS-targeted initiatives in Belgium
18:40
to
18:50
Networking zone 3 (N3)
Anton van Dijck
18:45
Oral presentation
Amphetamine-type stimulant use: global and European trends in the harm reduction response
18:45
to
19:00
Insights zone 3 (I3)
Sam Shirley-Beavan
18:50
Short communication
Estonia’s fentanyl battle: time to scale-up overdose prevention strategy?
18:50
to
19:00
Networking zone 4 (N4)
Sibella Hare Breidahl
Short communication
Predicting the onset of ketamine use among frequent nightlife attendees
18:50
to
19:00
Networking zone 3 (N3)
Charlotte van Miltenburg
Oral presentation
HCV prevention — moderated exchange
18:50
to
19:10
Networking zone 2 (N2)
Christine Rolle
19:00
Short communication
Assessment of possibilities for raising the quality of health care provided to opioid users by increasing access to substitution treatment
19:00
to
19:10
Networking zone 4 (N4)
Boguslawa Bukowska
Short communication
Why a zero tolerance drug policy for festivals is not working (well)
19:00
to
19:10
Networking zone 3 (N3)
Jochen Schrooten
Oral presentation
Implementation of an educational intervention for safer injection in the European context: preliminary results from the EUROSIDER project
19:00
to
19:15
Insights zone 3 (I3)
Perrine Roux
19:10
Short communication
Rising incidence of ageing opioid users within the EU wide treatment
19:10
to
19:20
Networking zone 4 (N4)
Anne Marie Carew
Short communication
Towards gender-sensitive responses in the drugs field: Intersections between sexual violence, drug use in nightlife environments
19:10
to
19:20
Networking zone 3 (N3)
Cristiana Vale Pires
Oral presentation
Short presentation of developed materials and training curricula of Integrative Drogenhilfe
19:10
to
19:20
Networking zone 2 (N2)
Christine Rolle
19:20
Short communication
Setting up a HPLC in a 7-day psychedelic music festival: drug checking moving forward
19:20
to
19:30
Networking zone 3 (N3)
Daniel Martins
Oral presentation
HCV prevention — moderated discussion
19:20
to
19:30
Networking zone 2 (N2)
Gabi Becker
Short communication
The neglected public health problem of opioid use among offenders - why we have failed and where we can improve.
19:20
to
19:30
Networking zone 4 (N4)
Friday, 25 October
10:55
Oral presentation
Memory-focused cognitive therapy for cocaine use disorder: theory, procedures and preliminary evidence from an external pilot randomised controlled trial
10:55
to
11:10
Central square 1 (C1)
John Marsden
Oral presentation
Overdose deaths in people prescribed opioids for chronic non-cancer pain: Systematic review and meta-analysis
10:55
to
11:10
Insights zone 3 (I3)
Sarah Larney
11:10
Oral presentation
Treatment of youth with substance use disorder and co-existing mental disorder: the MOVE programme.
11:10
to
11:25
Central square 1 (C1)
Mads Uffe Pedersen
Oral presentation
Hidden aspects of the opioid crisis: what factors are driving ageing trends among those using opioid drugs?
11:10
to
11:25
Insights zone 3 (I3)
Anne Marie Carew
11:25
Oral presentation
The impact of maternal alexithymia on parenting behaviours in the context of substance use disorders
11:25
to
11:40
Central square 1 (C1)
Alessio Porreca
Oral presentation
Comparing rates and characteristics of harms across different pharmaceutical opioids: an examination of Australian ambulance attendances 2013-2018.
11:25
to
11:40
Insights zone 3 (I3)
Tina Lam
11:40
Oral presentation
The role of social environment in pathways to recovery: a scoping review
11:40
to
11:55
Central square 1 (C1)
João Pedro Ramos
Oral presentation
Causes of death among patients in opioid maintenance treatment in Norway
11:40
to
11:55
Insights zone 3 (I3)
Anne Berit Bech
11:55
Oral presentation
Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs
11:55
to
12:10
Insights zone 3 (I3)
Kirsten Trayner